Tech Company Financing Transactions

Tesaro Funding Round

New Enterprise Associates and private investors participated in a $20 million Series A venture round for Tesaro. The funding round closed on 5/26/2010.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1000 Winter St.
Waltham, MA 02451
USA

Phone

(339) 970-0900

Website

www.tesarobio.com

Email Address

[email protected]

Overview

TESARO (NASDAQ: TSRO) is an oncology-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Lonnie Moulder

        

Chief Financial Officer

Timothy Pearson

        

Chief Medical Officer

Martin Huber

        

President

Mary Hedley

        

Vice President

Orlando Oliveira

        

VP - Bus. Development

Grant Bogle

        

VP - Bus. Development

Allene Diaz

        

VP - General Counsel

Joseph Farmer

        

VP - Human Resources

Michelle Graham

        

VP - Operations

William Aitchison

        

VP - Regulatory Affairs

Jennifer Jackson

        

Browse more venture capital transactions:

Prev: 5/25/2010: Expressor Software venture capital transaction
Next: 5/26/2010: Innova Dynamics venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary